Nitrome Biosciences

Founded 

 in 

Nitrome has opened up an entirely new area of biology—the regulated nitration of proteins in healthy and disease states. Nitrome Biosciences is a platform company developing drugs against a newly identified class of enzymes to target Parkinson’s disease and other age-related disorders. Nitrome Biosciences is a platform company developing drugs against a newly identified class of enzymes to target Parkinson’s disease and other age-related disorders. The benefits to patient health and scientific understand may be tremendous. It is not often that an entirely new class of enzymes is discovered, particularly ones that have the potential to alter the course of neurodegeneration.

Irene Griswold-Prenner

Stay Tuned

Subscribe to our newsletter and get updates on our portfolio companies.